Ole Westergaard
- Toxicology top 0.1%
- Bioactive Compounds and Antitumor Agents 10
- Molecular Biology top 2%
- Cancer therapeutics and mechanisms 53
- DNA and Nucleic Acid Chemistry 31
- DNA Repair Mechanisms 27
- Protist diversity and phylogeny 15
- RNA modifications and cancer 8
- RNA and protein synthesis mechanisms 8
- Oncology top 5%
- Molecular Medicine top 5%
- Pharmacology top 5%
-
- Synthesis and Biological Evaluation 10
- Co-authors
- Bjarne J. BonvenAnni H. AndersenElmar GockeK. ChristiansenJesper Q. SvejstrupBo ThomsenEigil KjeldsenJan Alsner
- Cited by
- ToxicologyMolecular BiologyOncology
- Journals
- Journal of Biological Chemistry (17 papers)Journal of Molecular Biology (13 papers)Nucleic Acids Research (11 papers)
- Partner nations
- DenmarkUnited StatesGermany
In The Last Decade
Ole Westergaard
92 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 93
- Toxicology 669
- Molecular Biology 3.4k
- Oncology 965
- Molecular Medicine 79
- Pharmacology 242
Countries citing papers authored by Ole Westergaard
This map shows the geographic impact of Ole Westergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Westergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Westergaard more than expected).
Fields of papers citing papers by Ole Westergaard
This network shows the impact of papers produced by Ole Westergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Westergaard. The network helps show where Ole Westergaard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ole Westergaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 2 | |
| 2 | 2001 | 1 | |
| 3 | 2001 | 44 | |
| 4 | 2000 | 36 | |
| 5 | 2000 | 38 | |
| 6 | 2000 | 4 | |
| 7 | 1999 | 29 | |
| 8 | 1998 | 5 | |
| 9 | 1997 | 19 | |
| 10 | 1996 | 2 | |
| 11 | 1996 | 7 | |
| 12 | 1996 | 8 | |
| 13 | 1995 | 41 | |
| 14 | 1994 | 10 | |
| 15 | 1992 | 107 | |
| 16 | 1991 | 26 | |
| 17 | 1990 | 51 | |
| 18 | 1989 | 112 | |
| 19 | 1989 | 59 | |
| 20 | Studies on the structure of active versus inactive nucleolar chromatin from Tetrahymena | 1980 | 10 |
About Ole Westergaard
Ole Westergaard is a scholar working on Toxicology, Molecular Biology and Parasitology, having authored 92 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (53 papers), DNA and Nucleic Acid Chemistry (31 papers), DNA Repair Mechanisms (27 papers), Protist diversity and phylogeny (15 papers), Bioactive Compounds and Antitumor Agents (10 papers), Synthesis and Biological Evaluation (10 papers), RNA modifications and cancer (8 papers) and RNA and protein synthesis mechanisms (8 papers). The work is most often cited by research in Toxicology (669 citations), Molecular Biology (3.4k citations) and Oncology (965 citations). Ole Westergaard has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Bjarne J. Bonven, Anni H. Andersen, Elmar Gocke, K. Christiansen, Jesper Q. Svejstrup, Bo Thomsen, Eigil Kjeldsen, Jan Alsner, Kent Christiansen and Birgitta R. Knudsen. Their work appears in journals such as Journal of Biological Chemistry, Journal of Molecular Biology, Nucleic Acids Research, Biochemistry and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.